Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathilda Mennen

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Medical & Biological Engineering & Computing|April 14, 2026
Deep learning for carotid Doppler spectra classificationCharita Bhikha, Kahesh Dhuness, Mathilda Mennen, et al.
Cell Reports. Medicine|December 30, 2022
Impact of SARS-CoV-2 exposure history on the T cell and IgG responseRoanne Keeton, Marius B Tincho, Akiko Suzuki, et al.
Global Heart|April 19, 2024
Greater Disease Severity and Worse Clinical Outcomes in Patients Hospitalised with COVID-19 in AfricaLina Hahnle, Mathilda Mennen, Freedom Gumedze, et al.
Cell Host & Microbe|January 11, 2024
Post-pandemic memory T cell response to SARS-CoV-2 is durable, broadly targeted, and cross-reactive to the hypermutated BA.2.86 variantRofhiwa Nesamari, Millicent A Omondi, Richard Baguma, et al.
Cell Reports. Medicine|March 2, 2022
SARS-CoV-2 Beta and Delta variants trigger Fc effector function with increased cross-reactivitySimone I Richardson, Nelia P Manamela, Boitumelo M Motsoeneng, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2023
Distinct T cell functional profiles in SARS-CoV-2 seropositive and seronegative children associated with endemic human coronavirus cross-reactivityNtombi S B Benede, Marius B Tincho, Avril Walters, et al.
NPJ Vaccines|August 12, 2023
Infection pre-Ad26.COV2.S-vaccination primes greater class switching and reduced CXCR5 expression by SARS-CoV-2-specific memory B cellsRobert G E Krause, Thandeka Moyo-Gwete, Simone I Richardson, et al.
Plos Pathogens|November 9, 2023
Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infectionThandeka Moyo-Gwete, Simone I Richardson, Roanne Keeton, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2021
SARS-CoV-2 501Y.V2 (B.1.351) elicits cross-reactive neutralizing antibodiesThandeka Moyo-Gwete, Mashudu Madzivhandila, Zanele Makhado, et al.
The New England Journal of Medicine|April 7, 2021
Cross-Reactive Neutralizing Antibody Responses Elicited by SARS-CoV-2 501Y.V2 (B.1.351)Thandeka Moyo-Gwete, Mashudu Madzivhandila, Zanele Makhado, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Medical & Biological Engineering & Computing|April 14, 2026
Deep learning for carotid Doppler spectra classificationCharita Bhikha, Kahesh Dhuness, Mathilda Mennen, et al.
Cell Reports. Medicine|December 30, 2022
Impact of SARS-CoV-2 exposure history on the T cell and IgG responseRoanne Keeton, Marius B Tincho, Akiko Suzuki, et al.
Global Heart|April 19, 2024
Greater Disease Severity and Worse Clinical Outcomes in Patients Hospitalised with COVID-19 in AfricaLina Hahnle, Mathilda Mennen, Freedom Gumedze, et al.
Cell Host & Microbe|January 11, 2024
Post-pandemic memory T cell response to SARS-CoV-2 is durable, broadly targeted, and cross-reactive to the hypermutated BA.2.86 variantRofhiwa Nesamari, Millicent A Omondi, Richard Baguma, et al.
Cell Reports. Medicine|March 2, 2022
SARS-CoV-2 Beta and Delta variants trigger Fc effector function with increased cross-reactivitySimone I Richardson, Nelia P Manamela, Boitumelo M Motsoeneng, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2023
Distinct T cell functional profiles in SARS-CoV-2 seropositive and seronegative children associated with endemic human coronavirus cross-reactivityNtombi S B Benede, Marius B Tincho, Avril Walters, et al.
NPJ Vaccines|August 12, 2023
Infection pre-Ad26.COV2.S-vaccination primes greater class switching and reduced CXCR5 expression by SARS-CoV-2-specific memory B cellsRobert G E Krause, Thandeka Moyo-Gwete, Simone I Richardson, et al.
Plos Pathogens|November 9, 2023
Homologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infectionThandeka Moyo-Gwete, Simone I Richardson, Roanne Keeton, et al.
Biorxiv : the Preprint Server for Biology|March 10, 2021
SARS-CoV-2 501Y.V2 (B.1.351) elicits cross-reactive neutralizing antibodiesThandeka Moyo-Gwete, Mashudu Madzivhandila, Zanele Makhado, et al.
The New England Journal of Medicine|April 7, 2021
Cross-Reactive Neutralizing Antibody Responses Elicited by SARS-CoV-2 501Y.V2 (B.1.351)Thandeka Moyo-Gwete, Mashudu Madzivhandila, Zanele Makhado, et al.
Pageof 2